H.R. 4273 · 119th Congress · Health
Over-the-Counter Monograph Drug User Fee Amendments
Amends over-the-counter drug user fee provisions. AI-read
- IntroducedJul 2, 2025 Done
- CommitteeReported Sep 17, 2025 Done
- House floorAwaiting vote Current stage
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Became law inside another bill: its text was enacted in H.R. 5371 (Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs…), signed Nov 12, 2025. The bar shows how far this bill got under its own number.
What it does
This bill reauthorizes the Over-the-Counter (OTC) Monograph Drug User Fee Program (OMUFA) through FY2030 and revises certain aspects of the program, including total fees to be collected and fee due dates.
Under current law, many OTC drugs are marketed through compliance with an OTC monograph issued by the Food and Drug Administration (FDA), rather than through an approved new drug application. Monographs establish the conditions under which OTC drugs are generally recognized as safe and effective, and include ingredients, dosages, and other requirements. OMUFA permits the FDA to collect fees from OTC drug facilities and entities requesting changes to a monograph.
The bill makes certain changes to OMUFA, including by
• revising the total facility fee revenue amount to be collected for FY2026-FY2030,
• revising due dates for facility fees,
• permitting the FDA to implement a one-time adjustment to facility fees if certain conditions exist, and
• requiring the FDA to publish facility and order request fee amounts at least 60 days before the start of each fiscal year.
Finally, the bill adds as a Tier 2 OTC monograph order request a request for the addition or modification of a testing procedure applicable to a monograph drug, provided the testing procedure reflects a voluntary consensus standard with respect to pharmaceutical quality. (Requestors seeking certain kinds of changes to a monograph are awarded a period of market exclusivity if the FDA makes the requested changes; tier 2 requests are not eligible for market exclusivity.)
Congressional Research Service · summary of “Introduced in House” version · Jul 2, 2025
Who lobbies on it
8 organizations, more than 96% of House bills · 27 filings · Q3 2025–Q3 2026These 8 organizations’ PACs gave $51.5K to 4 of the 4 members sponsoring or cosponsoring H.R. 4273 in the 2025–26 election cycle.
One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
American Academy of Dermatology Association
5 of 5 quarters
“H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment”
$3.2M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
National Treasury Employees Union
5 of 5 quarters
“…H.R. 4273, Over-the-Counter Monograph Drug User Fee Amendments H.R. 4765, Securing our Border Act H.R. 5130, Prevent Government Shutdowns Act of 2025 S. 2721, Prevent Government Shutdowns Act of 2025 H.R. 5220, Congressional Power of the Purse Act H.R. 5260, Pay Our Border Patrol and Customs Agents Act H.R. 5398, Pay…”
$960K lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Consumer Healthcare Products Association
5 of 5 quarters
“S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and…”
Under $5,000 lobbying spend in 2026 to date, all issuesQ3 2026 filing
5 more organizations, every filingPROUpgrade
Organizations that named H.R. 4273 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
6 actions · newest first- Sep 17, 2025Placed on the Union Calendar, Calendar No. 254.
- Sep 17, 2025Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-300.
- Jul 23, 2025Ordered to be Reported (Amended) by the Yeas and Nays: 51 - 0.
- Jul 23, 2025Committee Consideration and Mark-up Session Held
Show all 6 actionsShow fewer
- Jul 2, 2025Referred to the House Committee on Energy and Commerce.
- Jul 2, 2025Introduced in House